Mr. Jones added, “Annexon is leading the development of first-in-kind upstream complement medicines with significant opportunities across neuroinflammatory diseases that have yet to be unlocked. I ...
In recent years, coworking spaces have become more than a trend—they’ve transformed how professionals and businesses approach ...